Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States.
Calcif. Tissue Int., Apr;82(4):271-7 (2008)
Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs.
J. Clin. Endocrinol. Metab., Aug;87(8):3656-61 (2002)
Is thyroid frozen section too much for too little?
Am. J. Surg., Dec;184(6):510-4; discussion 514 (2002)
Practical guide to the management of osteoporosis in men with prostate cancer receiving androgen-deprivation therapy.
Curr Urol Rep., May;6(3):157-8 (2005)
Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hydroxyvitamin d status.
Endocr Pract., 11(1):37-42 (2005)
Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.
Urology., Jan;67(1):152-5 (2006)
Effects of alendronate on bone mineral density in men with prostate cancer treated with androgen deprivation therapy.
J Clin Densitom., 9(4):431-7 (2006)
Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain.
J. Clin. Endocrinol. Metab., Nov;84(11):3867-71 (1999)
Dehydroepiandrosterone stimulates the estrogen response element.
J. Steroid Biochem. Mol. Biol., Aug;62(5-6):461-6 (1997)
Evaluation and treatment of postmenopausal osteoporosis.
Am J Manag Care., Sep;7 Spec No:SP5-16 (2001)
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
J. Clin. Invest., Jun;105(12):1833-8 (2000)
Evidence for transcriptional inhibition of GnRH gene expression by phorbol ester at a proximal promoter region.
Mol. Cell. Endocrinol., Mar;99(2):177-82 (1994)
Hypothyroidism-induced macroorchidism: use of a gonadotropin-releasing hormone agonist to understand its mechanism and augment adult stature.
J. Clin. Endocrinol. Metab., Jan;80(1):11-6 (1995)
Regulation of gonadotropin-releasing hormone (GnRH) gene expression in hypothalamic neuronal cells.
Cell. Mol. Neurobiol., Feb;15(1):79-88 (1995)
Phorbol ester activation of the protein kinase C pathway inhibits gonadotropin-releasing hormone gene expression.
Endocrinology., Dec;131(6):2552-8 (1992)
Phorbol ester inhibition of rat gonadotropin-releasing hormone promoter activity: role of Fos and Jun in the repression of transcription.
Mol. Endocrinol., Jan;10(1):35-44 (1996)